Menu
Currency
GWAS Study

Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma.

Pistoni L, Gentiluomo M, Lu Y et al.

34216462 PubMed ID
GWAS Study Type
57497 Participants
59 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

PL
Pistoni L
GM
Gentiluomo M
LY
Lu Y
LD
López de Maturana E
HV
Hlavac V
VG
Vanella G
DE
Darvasi E
MA
Milanetto AC
OM
Oliverius M
VY
Vashist Y
DL
Di Leo M
MB
Mohelnikova-Duchonova B
TR
Talar-Wojnarowska R
GC
Gheorghe C
PM
Petrone MC
SO
Strobel O
AP
Arcidiacono PG
VL
Vodickova L
SA
Szentesi A
CG
Capurso G
GL
Gajdán L
MG
Malleo G
TG
Theodoropoulos GE
BD
Basso D
SP
Soucek P
BH
Brenner H
LR
Lawlor RT
ML
Morelli L
IA
Ivanauskas A
KE
Kauffmann EF
MA
Macauda A
GM
Gazouli M
AL
Archibugi L
NM
Nentwich M
LM
Loveček M
CG
Cavestro GM
VP
Vodicka P
LS
Landi S
TF
Tavano F
SC
Sperti C
HT
Hackert T
KJ
Kupcinskas J
PR
Pezzilli R
AA
Andriulli A
PL
Pollina L
KE
Kreivenaite E
GD
Gioffreda D
JK
Jamroziak K
HP
Hegyi P
IJ
Izbicki JR
TS
Testoni SGG
ZR
Zuppardo RA
BD
Bozzato D
NJ
Neoptolemos JP
MN
Malats N
CF
Canzian F
CD
Campa D
Chapter II

Abstract

Summary of the research findings

Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers. Its poor prognosis is predominantly due to the fact that most patients remain asymptomatic until the disease reaches an advanced stage, alongside the lack of early markers and screening strategies. A better understanding of PDAC risk factors is essential for the identification of groups at high risk in the population. Genome-wide association studies (GWAS) have been a powerful tool for detecting genetic variants associated with complex traits, including pancreatic cancer. By exploiting functional and GWAS data, we investigated the associations between polymorphisms affecting gene function in the pancreas (expression quantitative trait loci, eQTLs) and PDAC risk. In a two-phase approach, we analysed 13 713 PDAC cases and 43 784 controls and identified a genome-wide significant association between the A allele of the rs2035875 polymorphism and increased PDAC risk (P = 7.14 × 10-10). This allele is known to be associated with increased expression in the pancreas of the keratin genes KRT8 and KRT18, whose increased levels have been reported to correlate with various tumour cell characteristics. Additionally, the A allele of the rs789744 variant was associated with decreased risk of developing PDAC (P = 3.56 × 10-6). This single nucleotide polymorphism is situated in the SRGAP1 gene and the A allele is associated with higher expression of the gene, which in turn inactivates the cyclin-dependent protein 42 (CDC42) gene expression, thus decreasing the risk of PDAC. In conclusion, we present here a functional-based novel PDAC risk locus and an additional strong candidate supported by significant associations and plausible biological mechanisms.

7,207 European ancestry cases, 7,062 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

57497
Total Participants
GWAS
Study Type
Yes
Replicated
2,039 Japanese ancestry cases, 32,592 Japanese ancestry controls, 4,467 cases, 4,130 controls
Replication Participants
East Asian, European
Ancestry
Japan, Hungary, Republic of Ireland, Ukraine, Spain, Greece, Netherlands, Czech Republic, Sweden, Denmark, Poland, Italy, U.K., Lithuania, Germany
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.